Brian L. Koopman - 24 Dec 2018 Form 4 Insider Report for UTAH MEDICAL PRODUCTS INC (UTMD)

Role
Principal Financial Officer
Signature
/s/ Brian L. Koopman
Issuer symbol
UTMD
Transactions as of
24 Dec 2018
Net transactions value
$0
Form type
4
Filing time
28 Oct 2021, 11:36:36 UTC
Next filing
28 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTMD Employee Stock Option - Right to Buy Award $0 +1,600 $0.000000 1,600 24 Dec 2018 Common Stock 1,600 $74.64 Direct F1
transaction UTMD Employee Stock Option - Right to Buy Award $0 +2,000 +125% $0.000000 3,600 20 Mar 2020 Common Stock 2,000 $77.05 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option will vest 25% on 1/1/2020, and at an additional 6.25% on 4/1/2020 and on the first day of each calendar quarter thereafter. Fully exercisable on 1/1/2023.
F2 Option will vest 25% on 4/1/2021, and at an additional 6.25% on 7/1/2021 and on the first day of each calendar quarter thereafter. Fully exercisable on 4/1/2024.